From: Clinical features and outcomes of germline mutation BRCA1-linked versus sporadic ovarian cancer patients
Germline mutation
All ovarian cancer (n = 125)
5382insC [exon 20]
12/125 (9.6 %)
300 T > G [exon 5]
3/125 (2.4 %)
4153delA [exon 11.17]
2/125 (1.6 %)
All mutations
17/125 (13.6 %)